Back to Search

GARY NORONHA, MD

MD

Internal Medicine Physician

NPI: 1649222704IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Physician Assistant

Physician Assistant — Medical

Code: 363AM0700X

268181(NY)
Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

268181(NY)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

OTHER

Class of 1999

Research & Publications (16)

Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
PMID 19056934·J Pharmacol Exp Ther·2009
7-preclinical
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.
PMID 18483622·J Clin Invest·2008
7-preclinical
Inhibitors of ABL and the ABL-T315I mutation.
PMID 18673174·Curr Top Med Chem·2008
8-other
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
PMID 18394554·Cancer Cell·2008
7-preclinical
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
PMID 18330892·J Cell Physiol·2008
7-preclinical
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
PMID 18311895·J Med Chem·2008
7-preclinical
Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors.
PMID 18394555·Cancer Cell·2008
7-preclinical
Discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarction.
PMID 17685602·J Med Chem·2007
7-preclinical
The design and preliminary structure-activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymes.
PMID 17827012·Bioorg Med Chem Lett·2007
8-other
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.
PMID 17541402·Leukemia·2007
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
2300 W JEFFERSON RD STE 400
PITTSFORD, NY 14534

Quick Facts

NPI
1649222704
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
27
Publications
16

Are you this provider?

Claim Your Profile